Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 454162, 11 pages
http://dx.doi.org/10.1155/2015/454162
Research Article

Modifications in Bone Matrix of Estrogen-Deficient Rats Treated with Intermittent PTH

1Department of Morphology and Genetics, School of Medicine, Federal University of São Paulo, 04023-900 São Paulo, SP, Brazil
2Mineralized Tissue and Histology Research Laboratory, Department of Morphology and Genetics, Federal University of São Paulo School of Medicine (UNIFESP), Rua Botucatu, 740 Vila Clementino, 04023-900 São Paulo, SP, Brazil
3Department of Biochemistry, School of Medicine, Federal University of São Paulo, 04044-020 São Paulo, SP, Brazil
4Department of Physiological Sciences, Federal University of São Carlos, 13565-905 São Carlos, SP, Brazil
5Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
6Roudebush Veterans Administration Medical Center, Indianapolis, IN 46202, USA

Received 26 July 2014; Revised 21 November 2014; Accepted 21 November 2014

Academic Editor: Kazim Husain

Copyright © 2015 Rafael Pacheco-Costa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Teti, “Bone development: overview of bone cells and signaling,” Current Osteoporosis Reports, vol. 9, no. 4, pp. 264–273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. W. Dempster and R. Lindsay, “Pathogenesis of osteoporosis,” The Lancet, vol. 341, no. 8848, pp. 797–801, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Khosla, M. J. Oursler, and D. G. Monroe, “Estrogen and the skeleton,” Trends in Endocrinology and Metabolism, vol. 23, no. 11, pp. 576–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Kanis, E. V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli, and J. Y. Reginster, “European guidance for the diagnosis and management of osteoporosis in postmenopausal women,” Osteoporosis International, vol. 24, no. 1, pp. 23–57, 2013. View at Publisher · View at Google Scholar
  5. T. Bellido, A. A. Ali, L. I. Plotkin et al., “Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts: a putative explanation for why intermittent administration is needed for bone anabolism,” The Journal of Biological Chemistry, vol. 278, no. 50, pp. 50259–50272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Schnoke, S. B. Midura, and R. J. Midura, “Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair,” Bone, vol. 45, no. 3, pp. 590–602, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. L. Jilka, R. S. Weinstein, T. Bellido, P. Roberson, A. M. Parfitt, and S. C. Manolagas, “Increased bone formation byprevention of osteoblast apoptosis with parathyroid hormone,” The Journal of Clinical Investigation, vol. 104, no. 4, pp. 439–446, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Midura, X. Su, J. A. Morcuende, M. Tammi, and R. Tammi, “Parathyroid hormone rapidly stimulates hyaluronan synthesis by periosteal osteoblasts in the tibial diaphysis of the growing rat,” Journal of Biological Chemistry, vol. 278, no. 51, pp. 51462–51468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Ogihara, N. Suda, V. E. Hammond, P. V. Senior, F. Beck, and M. Yanagishita, “Biosynthesis of proteoglycan in bone and cartilage of parathyroid hormone-related protein knockout mice,” Journal of Bone and Mineral Metabolism, vol. 19, no. 1, pp. 4–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. D. Berendsen, E. L. Pinnow, A. Maeda et al., “Biglycan modulates angiogenesis and bone formation during fracture healing,” Matrix Biology, vol. 35, pp. 223–231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. W. Prince, “Roles of hyaluronan in bone resorption,” BMC Musculoskeletal Disorders, vol. 5, article 12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. W. Prince, F. Rahemtulla, and W. T. Butler, “Metabolism of rat bone proteoglycans in vivo,” Biochemical Journal, vol. 216, no. 3, pp. 589–596, 1983. View at Google Scholar · View at Scopus
  13. P. Bianco, L. W. Fisher, M. F. Young, J. D. Termine, and P. G. Robey, “Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues,” Journal of Histochemistry and Cytochemistry, vol. 38, no. 11, pp. 1549–1563, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Rucci, A. Rufo, M. Alamanou et al., “The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-κB inhibitor that impairs osteoclastogenesis,” Journal of Cell Biology, vol. 187, no. 5, pp. 669–683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. R. Amend, O. Uluckan, M. Hurchla et al., “Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts,” Journal of Bone and Mineral Research, 2014. View at Publisher · View at Google Scholar
  16. T. Xu, P. Bianco, L. W. Fisher et al., “Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice,” Nature Genetics, vol. 20, no. 1, pp. 78–82, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Hofstetter, S. Gamsjaeger, F. Varga et al., “Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy,” Osteoporosis International, vol. 25, no. 12, pp. 2709–2719, 2014. View at Publisher · View at Google Scholar
  18. E. P. Paschalis, E. V. Glass, D. W. Donley, and E. F. Eriksen, “Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 8, pp. 4644–4649, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. E. P. Paschalis, D. B. Burr, R. Mendelsohn, J. M. Hock, and A. L. Boskey, “Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1–34) for 18 months,” Journal of Bone and Mineral Research, vol. 18, no. 4, pp. 769–775, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. D. N. Kalu, “The ovariectomized rat model of postmenopausal bone loss,” Bone and Mineral, vol. 15, no. 3, pp. 175–191, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Florencio-Silva, M. A. Santos, V. P. De Medeiros et al., “Effects of soy isoflavones and mechanical vibration on rat bone tissue,” Climacteric, vol. 16, no. 6, pp. 709–717, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Santos, R. Florencio-Silva, V. P. Medeiros et al., “Effects of different doses of soy isoflavones on bone tissue of ovariectomized rats,” Climacteric, vol. 17, pp. 393–401, 2014. View at Google Scholar
  23. E. Shorr, “A new technic for staining vaginal smears: III, a single differential stain,” Science, vol. 94, no. 2449, pp. 545–546, 1941. View at Google Scholar · View at Scopus
  24. D. W. Dempster, J. E. Compston, M. K. Drezner et al., “Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee,” Journal of Bone and Mineral Research, vol. 28, no. 1, pp. 2–17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. L. C. U. Junqueira, G. Bignolas, and R. R. Brentani, “Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections,” The Histochemical Journal, vol. 11, no. 4, pp. 447–455, 1979. View at Publisher · View at Google Scholar · View at Scopus
  26. R. C. Teixeira Gomes, C. Verna, H. B. Nader et al., “Concentration and distribution of hyaluronic acid in mouse uterus throughout the estrous cycle,” Fertility and Sterility, vol. 92, no. 2, pp. 785–792, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. R. M. Martins, C. C. Passerotti, R. M. B. Maciel, L. O. Sampaio, C. P. Dietrich, and H. B. Nader, “Practical determination of hyaluronan by a new noncompetitive fluorescence-based assay on serum of normal and cirrhotic patients,” Analytical Biochemistry, vol. 319, no. 1, pp. 65–72, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. C. E. Franciozi, V. A. F. Tarini, R. D. Reginato et al., “Gradual strenuous running regimen predisposes to osteoarthritis due to cartilage cell death and altered levels of glycosaminoglycans,” Osteoarthritis and Cartilage, vol. 21, no. 7, pp. 965–972, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. P. S. Faloni, E. Sasso-Cerri, E. Katchburian, and P. S. Cerri, “Decrease in the number and apoptosis of alveolar bone osteoclasts in estrogen-treated rats,” Journal of Periodontal Research, vol. 42, no. 3, pp. 193–201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. P. Dietrich and S. M. C. Dietrich, “Electrophoretic behaviour of acidic mucopolysaccharides in diamine buffers,” Analytical Biochemistry, vol. 70, no. 2, pp. 645–647, 1976. View at Publisher · View at Google Scholar · View at Scopus
  31. L. A. de Souza Merli, V. P. de Medeiros, L. Toma et al., “The low level laser therapy effect on the remodeling of bone extracellular matrix,” Photochemistry and Photobiology, vol. 88, no. 5, pp. 1293–1301, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Iida-Klein, H. Zhou, S. S. Lu et al., “Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice,” Journal of Bone and Mineral Research, vol. 17, no. 5, pp. 808–816, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Arita, S. Ikeda, A. Sakai et al., “Human parathyroid hormone (1–34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats,” Journal of Bone and Mineral Metabolism, vol. 22, no. 6, pp. 530–540, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Rhee, M. R. Allen, K. Condon et al., “PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling,” Journal of Bone and Mineral Research, vol. 26, no. 5, pp. 1035–1046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. C. Gallagher, C. J. Rosen, P. Chen, D. A. Misurski, and R. Marcus, “Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis,” Bone, vol. 39, no. 6, pp. 1268–1275, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Montero, D. Serfati, S. Luna et al., “The effectiveness of intermittent rat parathyroid hormone (1–34) treatment on low bone mass due to oestrogen or androgen depletion in skeletally mature rats,” Aging Male, vol. 13, no. 1, pp. 59–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Del Fattore, A. Cappariello, M. Capulli et al., “An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6,” Osteoporosis International, vol. 25, no. 2, pp. 681–692, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. U. Comelekoglu, S. Bagis, S. Yalin et al., “Biomechanical evaluation in osteoporosis: ovariectomized rat model,” Clinical Rheumatology, vol. 26, no. 3, pp. 380–384, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. R. T. Turner, G. L. Evans, S. Lotinun, P. D. Lapke, U. T. Iwaniec, and E. Morey-Holton, “Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats,” Journal of Bone and Mineral Research, vol. 22, no. 1, pp. 64–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. R. M. Neer, C. D. Arnaud, J. R. Zanchetta et al., “Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis,” The New England Journal of Medicine, vol. 344, no. 19, pp. 1434–1441, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Clarke, “Normal bone anatomy and physiology,” Clinical Journal of the American Society of Nephrology, vol. 3, supplement 3, pp. S131–S139, 2008. View at Google Scholar
  42. M.-G. Ascenzi, V. P. Liao, B. M. Lee et al., “Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis,” Journal of Bone and Mineral Research, vol. 27, no. 3, pp. 702–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Oxlund, M. Barckman, G. Ortoft, and T. T. Andreassen, “Reduced concentrations of collagen cross-links are associated with reduced strength of bone,” Bone, vol. 17, no. 4, pp. 365S–371S, 1995. View at Google Scholar · View at Scopus
  44. A. J. Bailey, T. J. Sims, E. N. Ebbesen, J. P. Mansell, J. S. Thomsen, and L. Mosekilde, “Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength,” Calcified Tissue International, vol. 65, no. 3, pp. 203–210, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. A. J. Bailey, S. F. Wotton, T. J. Sims, and P. W. Thompson, “Biochemical changes in the collagen of human osteoporotic bone matrix,” Connective Tissue Research, vol. 29, no. 2, pp. 119–132, 1993. View at Publisher · View at Google Scholar · View at Scopus
  46. A. J. Bailey, S. F. Wotton, T. J. Sims, and P. W. Thompson, “Post-translational modifications in the collagen of human osteoporotic femoral head,” Biochemical and Biophysical Research Communications, vol. 185, no. 3, pp. 801–805, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. L. C. U. Junqueira, G. S. Montes, and E. M. Sanchez, “The influence of tissue section thickness on the study of collagen by the Picrosirius-polarization method,” Histochemistry, vol. 74, no. 1, pp. 153–156, 1982. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Hirshberg, M. Lib, A. Kozlovsky, and I. Kaplan, “The influence of inflammation on the polarization colors of collagen fibers in the wall of odontogenic keratocyst,” Oral Oncology, vol. 43, no. 3, pp. 278–282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Szendroi, G. Vajta, and L. Kovacs, “Polarization colours of collagen fibres: a sign of collagen production activity in fibrotic processes,” Acta Morphologica Hungarica, vol. 32, no. 1, pp. 47–55, 1984. View at Google Scholar · View at Scopus
  50. L. B. Retamoso, T. D. M. A. da Cunha, L. A. H. Knop, R. L. Shintcovsk, and O. M. Tanaka, “Organization and quantification of the collagen fibers in bone formation during orthodontic tooth movement,” Micron, vol. 40, no. 8, pp. 827–830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. S. Acerbo, A. T. Kwaczala, L. Yang, S. Judex, and L. M. Miller, “Alterations in collagen and mineral nanostructure observed in osteoporosis and pharmaceutical treatments using simultaneous small- and wide-angle X-ray scattering,” Calcified Tissue International, vol. 95, no. 5, pp. 446–456, 2014. View at Publisher · View at Google Scholar
  52. G. S. Montes, “Structural biology of the fibres of the collagenous and elastic systems,” Cell Biology International, vol. 20, no. 1, pp. 15–27, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. J. E. Onyia, L. M. Helvering, L. Gelbert et al., “Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray,” Journal of Cellular Biochemistry, vol. 95, no. 2, pp. 403–418, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Corsi, T. Xu, X.-D. Chen et al., “Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues,” Journal of Bone and Mineral Research, vol. 17, no. 7, pp. 1180–1189, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Hoshi, S. Kemmotsu, Y. Takeuchi, N. Amizuka, and H. Ozawa, “The primary calcification in bones follows removal of decorin and fusion of collagen fibrils,” Journal of Bone and Mineral Research, vol. 14, no. 2, pp. 273–280, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. N. S. Gandhi and R. L. Mancera, “The structure of glycosaminoglycans and their interactions with proteins,” Chemical Biology and Drug Design, vol. 72, no. 6, pp. 455–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Yamamoto, N. Nagaoka, A. Hirata et al., “Ultrastructural and immunohistochemical studies of medullary bone calcification, with special reference to sulphated glycosaminoglycans,” Journal of Electron Microscopy, vol. 54, no. 1, pp. 29–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. R. J. Midura, S. P. Evanko, and V. C. Hascall, “Parathyroid hormone stimulates hyaluronan synthesis in an osteoblast-like cell line,” Journal of Biological Chemistry, vol. 269, no. 18, pp. 13200–13206, 1994. View at Google Scholar · View at Scopus
  59. R. L. Jilka, “Molecular and cellular mechanisms of the anabolic effect of intermittent PTH,” Bone, vol. 40, no. 6, pp. 1434–1446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. R. L. Jilka, R. S. Weinstein, A. M. Parfitt, and S. C. Manolagas, “Quantifying osteoblast and osteocyte apoptosis: challenges and rewards,” Journal of Bone and Mineral Research, vol. 22, no. 10, pp. 1492–1501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Sastre, C. Borrás, D. García-Sala, A. Lloret, F. V. Pallardó, and J. Viña, “Mitochondrial damage in aging and apoptosis,” Annals of the New York Academy of Sciences, vol. 959, pp. 448–451, 2002. View at Google Scholar · View at Scopus
  62. S. Lotinun, J. D. Sibonga, and R. T. Turner, “Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression,” Endocrine, vol. 17, no. 1, pp. 29–36, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Stanislaus, X. Yang, J. D. Liang et al., “In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1–34) fragment,” Bone, vol. 27, no. 2, pp. 209–218, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. F. Rohwer and F. Azam, “Detection of DNA damage in prokaryotes by terminal deoxyribonucleotide transferase-mediated dUTP nick end labeling,” Applied and Environmental Microbiology, vol. 66, no. 3, pp. 1001–1006, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Kanoh, G. Takemura, J. Misao et al., “Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair,” Circulation, vol. 99, no. 21, pp. 2757–2764, 1999. View at Publisher · View at Google Scholar · View at Scopus
  66. J. E. Cleaver, “Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective,” Proceedings of the National Academy of Sciences of the United States of America, vol. 63, no. 2, pp. 428–435, 1969. View at Publisher · View at Google Scholar · View at Scopus
  67. L. I. Plotkin, “Apoptotic osteocytes and the control of targeted bone resorption,” Current Osteoporosis Reports, vol. 12, pp. 121–126, 2014. View at Google Scholar